Meet Our Experts

Please select a topic:

Thomas Fink

Thomas Fink

Corporate Finance

Nicola Henneberg-Busse

Nicola Henneberg-Busse

Business Development, Partnering & Licensing, Business Plans

Matthias Bräutigam

Matthias Bräutigam

Preclinical Development, R&D Strategies

Christian Nagelstrasser

Christian Nagelstrasser

Corporate Design

Daniel Sehrt

Daniel Sehrt

Clinical Development, R&D Strategies

Jürgen Conrad

Jürgen Conrad

Public Funding of R&D

Astrid Schott

Astrid Schott

Clinical Development, Interim Management, R&D Strategies

Michael Hildebrand

Michael Hildebrand

CMC, Preclinical Development

Frank S. Zollmann

Frank S. Zollmann

Clinical Development, Preclinical Development, R&D Strategies

Christian Wolf

Christian Wolf

Clinical Development, Interim Management, Medical Affairs

Wolfgang M. Roßberg

Wolfgang M. Roßberg

Toxicology, Medical Writing, Non-clinical Development, R&D Strategies

Anke Maaßen

Anke Maaßen

In Vitro Diagnostics – RA, QM, QA, CMC

Siglinde Dürr

Siglinde Dürr

Quality Management, Auditing, CMC

Mark Waring

Mark Waring

Drug Safety, Pharmacovigilance

Silke Sittner

Silke Sittner

Interim Management

Johannes Lampe

Johannes Lampe

Clinical Development, R&D Strategies

Jörg Täubel

Jörg Täubel

Clinical Pharmacology Cardiac Safety Expert

Pascal Piller

Pascal Piller

Preclinical Development, REACH, Regulatory Affairs, Test Laboratory Service

Michael Zimmermann

Michael Zimmermann

Medical Devices – Clinical and Regulatory Affairs

Carsten Schwenke

Carsten Schwenke

Statistics

Moritz Hillgenberg

Moritz Hillgenberg

Commercial Assessment, Market Research

Hans Hendriks

Hans Hendriks

Pre- and Early Clinical Development, R&D Strategies, Scientific and Medical Writing

Wolf-Stefan Richter

Wolf-Stefan Richter

Clinical Development, R&D Strategies

Sanna-Maria Käkönen

Sanna-Maria Käkönen

Non-clinical Development (oncology), Scientific Marketing, Scientific Writing

Jens Hoffmann

Jens Hoffmann

Preclinical Development, R&D Strategies